Skip to main content
. 2021 Jul 20;8:693387. doi: 10.3389/fsurg.2021.693387

Table 4.

Recent guidelines and recommendations on LT for CRLMs.

ILTS transplant oncology consensus conference (74) Grade of recommendation Recommendations by the Spanish Society of Liver Transplantation (73) Grade of recommendation
LT can be a viable option in highly selected patients with unresectable CRLM with only liver involvement moderate evidence and moderate recommendation In selected patients with unresectable liver metastases of colorectal cancer, LT could be considered only in the context of well-designed clinical trials and after a close evaluation by a multidisciplinary team composed by oncologists, hepatologists, and surgeons. 2B
LT for CRLM with low Oslo score ≤2 may improve the 5-year OS rates over those achieved with the current standard of care moderate evidence and moderate recommendation The optimal strategy for waiting list prioritization is not established and should be tailored according to the composition and length of the waiting list in each region. 2C
Minimization of immunosuppression is recommended low evidence and moderate recommendation The type of donor would be at the discretion of each transplant center according to local experience and length of stay in the waiting list. 2C
Aggressive treatment of all post-LT resectable recurrences is recommended low evidence and moderate recommendation
There is a need for an international registry to coordinate data collection and design further studies on LT for CRLM moderate evidence and moderate recommendation

CRLM, Colon Rectal Liver Metastases; LT, Liver Transplantation; OS, Overall Survival.